Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Bard Avaulta Vaginal Mesh Lawsuits Selected for First Trials in MDL March 22, 2013 Austin Kirk Add Your Comments The first of four separate federal trials involving problems with Bard Avaulta mesh will begin in June, after the federal judge presiding over thousands of similar vaginal mesh lawsuits denied a request made by plaintiffs to have the first batch of bellwether test cases tried at the same time. In a court order (PDF) issued on March 7, U.S. District Judge Joseph R. Goodwin determined that the first four Bard Avaulta lawsuits in the federal MDL will each receive an individual trial, rejecting a suggestion that a group of cases be tried at the same time as part of a consolidated trial. Earlier this month, plaintiffs filed a Motion asking that three cases be consolidated for trial before the same jury, or that the Court seat three separate juries to hear the same evidence during a single trial, but to deliberate separately for each case. Learn More About Vaginal Mesh / Bladder Sling Lawsuits Complications from transvaginal mesh may cause severe injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Vaginal Mesh / Bladder Sling Lawsuits Complications from transvaginal mesh may cause severe injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Judge Goodwin denied the request, and has indicated that four separate trials will be held in the U.S. District Court for the Southern District of West Virginia, where all federal lawsuits over Bard Avaulta mesh have been centralized as part of an MDL, or multi-district litigation. According to the pretrial order, the first Bard Avaulta trial in the federal court system will involve a lawsuit filed by Donna and Dan Cisson. That case will be followed by claims by Linda and Ron Rizzo, then Carolyn Jones, and Wanda and Greg Queen. According to another Order (PDF) issued in December, the first trial date is scheduled to begin on June 11, 2013. Thousands of Lawsuits Filed Over Vaginal Mesh Products These bellwether cases have been selected as test cases to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be offered throughout the vaginal mesh litigation, which includes thousands of lawsuits filed over the Bard Avaulta mesh and other similar products manufactured by other companies. Judge Goodwin currently presides over five different consolidated proceedings involving vaginal mesh products manufactured by C.R. Bard, American Medical Systems (AMS), Boston Scientific, Ethicon and Coloplast Corp., respectively. All of the cases involve similar allegations that the manufacturers sold dangerous and defective surgical mesh products used for transvaginal repair of pelvic organ prolapse (POP) or female stress urinary incontinence (SUI). Plaintiffs allege that they suffered injuries when the mesh eroded through the vagina, caused infections or other severe complications. The cases are centralized to reduce duplicative discovery, avoid conflicting rulings from different judges and to serve the convenience of the parties, witnesses and the courts. As part of the consolidated pretrial proceedings, a small group of cases are being prepared for early trial dates in each of the proceedings, known as “bellwether” cases. The outcomes of these trials may help the parties ultimately reach vaginal mesh settlement agreements in a large number of cases. Following the June trial date involving Bard Avaulta mesh, a series of three additional trials are scheduled to begin in December 2013 involving lawsuits filed over AMS mesh, Boston Scientific mesh and Ethicon Gynecare mesh. State Court Trials Have Resulted in Award of Millions in Damages The scheduled trial dates in the Bard Avaulta MDL will be the first cases in the federal court system to go before a jury. However, other cases have gone to trial in California state court and New Jersey state court. In July 2012, a California state court jury awarded $5.5 million in damages from Bard Avaulta mesh following a lawsuit brought by 53 year old Christine Scott, who alleged that design defects allowed the mesh to slice through her colon, resulting in at least eight additional surgeries. Last month, a New Jersey state court jury awarded $11.1 million damages in an Ethicon vaginal mesh lawsuit brought by Linda Gross of South Dakota, who required at least 18 surgeries that she claimed could have been avoided if the manufacturer had adequately warned consumers and the medical community about the possible risk of injuries. According to the latest updated (PDF) provided by the U.S. Judicial Panel on Multidistrict Litigation on March 5, Judge Goodwin’s West Virginia court is currently presiding over 1,956 Bard Avaulta lawsuits; 3,974 AMS vaginal mesh lawsuits; 2,317 Boston Scientific pelvic mesh lawsuits; 3,798 Ethicon Gynecare mesh lawsuits and 188 Coloplast bladder sling lawsuits. The number of lawsuits filed throughout the country has continued to increase since the FDA issued a warning in July 2011, indicating that thousands of women had reported suffering problems with vaginal mesh products. After a review of all available data, the FDA concluded that there was no evidence that transvaginal mesh provides any additional benefits when compared to more traditional surgery to repair pelvic organ prolapse. Tags: American Medical Systems (AMS), Bard, Bard Avaulta, Bard Avaulta Mesh, Bladder Sling, Boston Scientific, C. R. Bard, Ethicon, Gynecare, Gynecare Prolift, Johnson & Johnson, Transvaginal Mesh, Vaginal Mesh, Vaginal Sling Image Credit: | More Vaginal Mesh Lawsuit Stories Study Finds Some Transvaginal Mesh Degrades Within 2 Months After It Is Implanted October 29, 2024 Supreme Court Rejects J&J Bid to Overturn $302M Vaginal Mesh Lawsuit Award February 23, 2023 Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study January 16, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study January 16, 2023
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)